Boulding Mark Elliott - Insider Non-Derivative Transactions at PTC THERAPEUTICS, INC. (PTCT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 15, 2024, Boulding Mark Elliott's relationship to PTC THERAPEUTICS, INC. (PTCT) is Officer (EXEC. VP AND CLO), and currently has 92,389 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PTCT insiders.

Data Source: SEC.
Boulding Mark Elliott - Insider Non-Derivative Transactions of PTCT Common Stock
Boulding Mark Elliott - Insider Non-Derivative Transactions at PTCT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 16, 2024 Acquisition -- (Common Stock) 18000 0 89189
Feb 16, 2024 Acquisition -- (Common Stock) 3200 0 92389
Jan 31, 2024 Sell -- (Common Stock) 794 27.25 71189
Jan 10, 2024 Sell -- (Common Stock) 1938 29.01 71983
Jan 9, 2024 Sell -- (Common Stock) 1457 28.64 73921
Apr 18, 2023 Sell -- (Common Stock) 58631 51.42 75378
Apr 18, 2023 Sell -- (Common Stock) 3292 51.42 75378
Apr 18, 2023 M -- (Common Stock) 3292 30.86 78670
Apr 18, 2023 M -- (Common Stock) 58631 30.86 134009
Feb 1, 2023 Sell -- (Common Stock) 812 45.63 75378
Jan 12, 2023 Sell -- (Common Stock) 495 44.36 76190
Jan 11, 2023 Sell -- (Common Stock) 590 42.93 76685
Jan 10, 2023 Sell -- (Common Stock) 835 41.66 77275
Jan 6, 2023 Acquisition -- (Common Stock) 17000 0 78110